Hilde De Winter

1.8k total citations · 1 hit paper
32 papers, 1.2k citations indexed

About

Hilde De Winter is a scholar working on Immunology, Nephrology and Genetics. According to data from OpenAlex, Hilde De Winter has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 8 papers in Nephrology and 8 papers in Genetics. Recurrent topics in Hilde De Winter's work include Complement system in diseases (15 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Hilde De Winter is often cited by papers focused on Complement system in diseases (15 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal Transplantation Outcomes and Treatments (6 papers). Hilde De Winter collaborates with scholars based in United States, Belgium and United Kingdom. Hilde De Winter's co-authors include Filip Callewaert, Spero R. Cataland, Marie Scully, Flora Peyvandi, Johanna A. Kremer Hovinga, Paul Knöbl, Ara Metjian, Robert K. Zeldin, Javier de la Rubia and Katerina Pavenski and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Hilde De Winter

27 papers receiving 1.2k citations

Hit Papers

Caplacizumab Treatment for Acquired Thrombotic Thrombocyt... 2019 2026 2021 2023 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
    2019 602 citations Marie Scully, Spero R. Cataland et al. profile →

Peers

Hilde De Winter
Paolo Durigutto Italy
Salima Sadallah Switzerland
Michael A. Maldonado United States
CE van der Schoot Netherlands
Pascale Loiseau France
K B Elkon United States
Ghislaine Bernard France
Nicole Schlagwein Netherlands
Maike Büttner Germany
Cornelia M. Weyand United States
Paolo Durigutto Italy
Hilde De Winter
Citations per year, relative to Hilde De Winter Hilde De Winter (= 1×) peers Paolo Durigutto

Countries citing papers authored by Hilde De Winter

Since Specialization
Citations

This map shows the geographic impact of Hilde De Winter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilde De Winter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilde De Winter more than expected).

Fields of papers citing papers by Hilde De Winter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilde De Winter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilde De Winter. The network helps show where Hilde De Winter may publish in the future.

Co-authorship network of co-authors of Hilde De Winter

This figure shows the co-authorship network connecting the top 25 collaborators of Hilde De Winter. A scholar is included among the top collaborators of Hilde De Winter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilde De Winter. Hilde De Winter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stavropoulou, Vaia, Alison Ribeiro, Hilde De Winter, et al.. (2024). 612 Comprehensive biomarker analyses from a phase 1 study reveals marked tumor microenvironment modulation in patients with advanced solid tumors treated with MP0317, a FAP-localized CD40 agonistic DARPin. Regular and Young Investigator Award Abstracts. A704–A704. 1 indexed citations
3.
4.
Peyvandi, Flora, Spero R. Cataland, Marie Scully, et al.. (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood Advances. 5(8). 2137–2141. 50 indexed citations
5.
Jeger, Simone, Oliver Schönborn‐Kellenberger, Hilde De Winter, et al.. (2021). 170TiP A phase I study to characterize the safety and tolerability of MP0317, a tumor targeting FAP dependent CD40 agonist DARPin®, in patients with relapsed/refractory solid tumors. Annals of Oncology. 32. S1456–S1457. 1 indexed citations
6.
Peyvandi, Flora, Spero R. Cataland, Marie Scully, et al.. (2021). INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA. Hematology Transfusion and Cell Therapy. 43. S46–S47.
7.
Cataland, Spero R., Marie Scully, Flora Peyvandi, et al.. (2019). Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies. Blood. 134(Supplement_1). 4908–4908.
8.
Knoebl, Paul, Spero R. Cataland, Flora Peyvandi, et al.. (2019). Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of Thrombosis and Haemostasis. 18(2). 479–484. 41 indexed citations
9.
Sargentini‐Maier, Maria Laura, et al.. (2019). Clinical pharmacology of caplacizumab for the treatment of patients with acquired thrombotic thrombocytopenic purpura. Expert Review of Clinical Pharmacology. 12(6). 537–545. 45 indexed citations
10.
Peyvandi, Flora, Spero R. Cataland, Marie Scully, et al.. (2018). Integrated Efficacy Results from the Phase II and Phase III Studies with Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. Blood. 132(Supplement 1). 373–373. 5 indexed citations
11.
Scully, Marie, Spero R. Cataland, Flora Peyvandi, et al.. (2017). Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. Blood. 130(Suppl_1). LBA–1. 16 indexed citations
12.
Peyvandi, Flora, Marie Scully, Johanna A. Kremer Hovinga, et al.. (2017). Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 15(7). 1448–1452. 84 indexed citations
13.
Wedemeyer, Heiner, Hans Van Vlierberghe, Michael Gschwantler, et al.. (2006). 617 E1 therapeutic vaccination in patients with chronic HCV genotype 1 infection: Results of a 15-month, placebo-controlled trial. Journal of Hepatology. 44. S229–S229. 1 indexed citations
14.
Efron, Philip A., et al.. (2005). Delayed neutralization of interferon-γ prevents lethality in primate Gram-negative bacteremic shock. Critical Care Medicine. 33(4). 797–805. 10 indexed citations
15.
Neyrinck, Arne, Filip Rega, Lucie Fransen, et al.. (2004). Beta-adrenergic stimulation of alveolar liquid clearance: a novel strategy to resolve pulmonary edema after lung transplantation?. European Journal of Anaesthesiology. 21(Supplement 32). 163–164. 1 indexed citations
16.
Elewaut, Dirk, Kirsten J. L. Hammond, Hilde De Winter, et al.. (2003). NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells. The Journal of Experimental Medicine. 197(12). 1623–1633. 102 indexed citations
17.
Winter, Hilde De, Dirk Elewaut, Olga Turovskaya, et al.. (2002). Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology. 122(7). 1829–1841. 49 indexed citations
18.
Meester, Johan De, Hilde De Winter, Ludolf Erwin Meester, et al.. (2002). Which ABO-matching rule should be the decisive factor in the choice between a highly urgent and an elective patient?. Transplant International. 15(8). 431–435. 4 indexed citations
19.
Elewaut, Dirk, Laurent Brossay, Sybil M. Santee, et al.. (2000). Membrane Lymphotoxin Is Required for the Development of Different Subpopulations of NK T Cells. The Journal of Immunology. 165(2). 671–679. 55 indexed citations
20.
Verbanck, J., et al.. (1997). Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients. Journal of Clinical Ultrasound. 25(2). 53–56. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Durigutto Breakdown of academic impact, for papers by Salima Sadallah Breakdown of academic impact, for papers by Michael A. Maldonado Breakdown of academic impact, for papers by CE van der Schoot Breakdown of academic impact, for papers by Pascale Loiseau Breakdown of academic impact, for papers by K B Elkon Breakdown of academic impact, for papers by Ghislaine Bernard Breakdown of academic impact, for papers by Nicole Schlagwein Breakdown of academic impact, for papers by Maike Büttner Breakdown of academic impact, for papers by Cornelia M. Weyand
Rankless by CCL
2026